FYCO1 Protein — FYVE and Coiled-Coil Domain Containing 1
Introduction <table class="infobox infobox-protein">Protein Name </td>Gene </td>UniProt ID </td>Molecular Weight </td>Subcellular Localization </td>Protein Family </td>
...
FYCO1 Protein — FYVE and Coiled-Coil Domain Containing 1
Introduction <table class="infobox infobox-protein">Protein Name </td>Gene </td>UniProt ID </td>Molecular Weight </td>Subcellular Localization </td>Protein Family </td>
Fyco1 Protein — Fyve And Coiled Coil Domain Containing 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview This page provides comprehensive information about FYCO1 Protein, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.
Structure FYCO1 is a large autophagy adaptor protein containing multiple domains:
FYVE domain (residues 1-50) - binds PI3P on autophagosomesCoiled-coil regions (multiple) - mediate protein interactionsLIR (LC3-interacting region) (residues 400-420) - binds LC3/GABARAPRUN domain (residues 900-1100) - interacts with RAB GTPasesC-terminal regions - contain multiple protein-binding sitesBinding Partners
Normal Function FYCO1 is a selective autophagy receptor that coordinates:
Autophagosome Transport
Recruits autophagosomes to microtubules
Facilitates transport from periphery to perinuclear region
Promotes autophagosome-lysosome fusion
Autophagy Flux
Enhances autophagosome-lysosome fusion
Coordinates endosomal maturation
Supports selective autophagy
Cellular Homeostasis
Clears damaged organelles
Removes protein aggregates
Maintains neuronal health
Role in Disease
Hereditary Spastic Paraplegia (SPG59) FYCO1 mutations cause HSP through:
Impaired autophagic flux
Accumulation of damaged organelles
Axonal transport defects
Degeneration of corticospinal tract
Neurodegeneration FYCO1 deficiency leads to:
Impaired protein aggregate clearance Mitochondrial dysfunction Enhanced oxidative stress Lysosomal storage abnormalities Therapeutic Targeting
Key Publications
Mech et al. (2014) - "FYCO1 mutations cause SPG59." Nat Genet [@ravikumar2009]Pankiv et al. (2010) - "FYCO1 is an autophagy adaptor." J Cell Biol [@pankiv2007]Olsvik et al. (2015) - "FYCO1 in autophagosome-lysosome fusion." Autophagy [@kirkin2009]Wang et al. (2019) - "FYCO1 in neuronal autophagy." Brain [@rogov2014]
See Also
[FYCO1 Gene](/proteins/fyco1-protein)
[Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
[Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
[RAB Proteins](/entities/rab-proteins)
[LC3/GABARAP](/entities/lc3-gabarap)
[Protein Quality Control](/mechanisms/protein-quality-control-network)
External Links
[UniProt: FYCO1](https://www.uniprot.org/uniprot/Q9BQR1)
[NCBI Protein: FYCO1](https://www.ncbi.nlm.nih.gov/protein/Q9BQR1)
Disease Associations
Hereditary Spastic Paraplegia (SPG59)
[FYCO1 mutations * cause AR-SPG59](/genes/ar)
[First described in 2014 (Moiretti)](/genes/scrib)
[Characterized by:](/genes/ar)
[Early-onset spastic paraplegia](/genes/ar)
[Thin corpus callosum](/brain-regions/corpus-callosum)
[Cerebellar ataxia](/diseases/cerebellar-ataxia)
[Peripheral neuropathy](/cell-types/dorsal-root-ganglion-neuropathy)
Alzheimer's Disease
[FYCO1 in autophagosome-lysosome pathway](/genes/fyco1)
[Impaired autophagy in AD brains](/mechanisms/autophagy)
[Role in [tau](/proteins/tau) clearance](/proteins)
May contribute to protein aggregate accumulation
Parkinson's Disease
[FYCO1 ex](/genes/fyco1)pression in dopaminergic [neurons](/entities/neurons)
Role in [alpha-synuclein](/proteins/alpha-synuclein) clearance
Lysosomal dysfunction in PD
Autophagy impairment
Neurodegeneration
Autophagy-lysosomal pathway dysfunction
Protein aggregate accumulation
Mitochondrial quality control
Synaptic dysfunction
Therapeutic Approaches
Autophagy Enhancement
Rapamycin - [mTOR](/mechanisms/mtor-signaling-pathway) inhibitionMetformin - AMPK activationTrehalose - autophagy inducerLithium - autophagy enhancementGene Therapy
AAV-FYCO1 delivery
CRISPR-based approaches
siRNA targeting
Viral vector development
Small Molecules
[TFEB](/proteins/tfeb) activators
Autophagy modulators
Lysosomal function enhancers
Research Directions
Understanding FYCO1 mutation spectrum
Developing gene therapy approaches
Biomarker potential
Role in specific neuronal populations
Background The study of Fyco1 Protein — Fyve And Coiled Coil Domain Containing 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Ravikumar B, Futter M, Jahreiss L, et al, Mammalian atg18/WD repeat domain (2009)](https://pubmed.ncbi.nlm.nih.gov/19994112/)
[Pankiv S, Clausen TH, Lamark T, et al, p62/SQSTM1 binds to LC3 (2007)](https://pubmed.ncbi.nlm.nih.gov/17580304/)
[Kirkin V, McEwan DG, Novak I, Dikic I, A role for ubiquitin in selective autophagy (2009)](https://pubmed.ncbi.nlm.nih.gov/19494825/)
[Rogov V, Dotsch V, Johansen T, Kirkin V, Interactions between autophagy receptors and ubiquitin-binding proteins (2014)](https://pubmed.ncbi.nlm.nih.gov/24452368/)
[Bjorkoy G, Lamark T, Brech A, et al, p62 triggers autophagy (2005)](https://pubmed.ncbi.nlm.nih.gov/16286508/) Show full description